Induction of immune response to antigens expressed by recombinant adeno-associated virus
US6242426A · kind A · utility
2Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1998 |
| Grant date | Jun 5, 2001 |
| Priority date | — |
| Expiry date | Jul 23, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to immunization methods using recombinant viral vectors. In particular, the invention relates to methods and compositions for immunizing a subject with a nucleic acid molecule encoding an antigen of interest, wherein the nucleic acid molecule is delivered to the subject via a recombinant AAV virion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.